Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess™, its restorative vascular access conduit ...Middle East

aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, permanent, living vessel EINDHOVEN, The Netherlands, June 13, 2024 /PRNewswire/ -- Xeltis, a leading developer of transformative implants that enable the...

Hence then, the article about xeltis receives ide approval from fda for initiation of us pivotal trial for axess its restorative vascular access conduit was published today ( Thursday 13/06/2024 - 10:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess™, its restorative vascular access conduit )

Also on site :

• ‘The Debut’ Explodes at Telluride With Julianne Moore’s Gonzo, Career-Best Turn, Thanks to Bananas, Unlit Cigarettes and a Faux Musical
• ‘The Debut’ Features Seven Original Songs, All Written by Jesse Eisenberg, and One Is Getting an Oscar Push (Exclusive)
• 1971 Movie, Directed by Dennis Hopper, Launched a Music Legend’s Acting Career—Just as He Scored His First No. 1 Hit